伴有产KPC菌血症的天然二尖瓣心内膜炎经二尖瓣置换术及头孢他啶-阿维巴坦成功治疗。
Native mitral valve endocarditis associated with KPC producing bacteremia successfully treated with mitral valve replacement and ceftazidime-avibactam.
作者信息
Tilanus Alwin, Rincon Francisco Mauricio, Rivera Aura Maria
机构信息
Internist-Infectious Disease Specialist, Department of Infectious Diseases, Clinica Los Nogales, Calle 95 # 23 - 61, Bogotá, Colombia.
Cardiovascular Surgeon, Department of Cardiovascular Surgery, Clinica Los Nogales, Calle 95 # 23 - 61, Bogotá, Colombia.
出版信息
IDCases. 2021 Apr 26;24:e01137. doi: 10.1016/j.idcr.2021.e01137. eCollection 2021.
Consistent with global trends of infections due to multiple-drug resistant Gram-negative bacteria, we report the first official case of native mitral valve endocarditis due to multi-resistant Carbapenemase (KPC) producing . The patient underwent mitral valve replacement and was successfully treated with monotherapy ceftazidime-avibactam.
与耐多药革兰氏阴性菌感染的全球趋势一致，我们报告了首例由产多重耐药碳青霉烯酶（KPC）引起的原发性二尖瓣心内膜炎的官方病例。该患者接受了二尖瓣置换术，并成功接受了头孢他啶-阿维巴坦单药治疗。
Zotero 插件